Olema Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Olema Pharmaceuticals Inc
TickerOLMA
CIK #0001750284
CUSIP68062P106
SectorLife Sciences - Pharmaceutical Preparations
Address512 2Nd Street, 4th Floor, San Francisco, CA 94107
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Olema Pharmaceuticals Inc 2024-12-12 250.0 M Exemption: 506(b) · Remaining: $761 · Duration: One year or less · Commission: $12,500,000 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001750284] 10-K
[0001750284] 10-Q
[0001750284] 3
[0001750284] 4
[0001750284] 8-K
[0001750284] D
[0001750284] SC 13D
[0001750284] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Invus Global Management LLC Olema Pharmaceuticals Inc [2026-03-20] 0.0
FMR LLC Olema Pharmaceuticals Inc [2026-02-05] 0.0
Janus Henderson Group PLC Olema Pharmaceuticals Inc [2025-11-14] 0.0
Bain Capital Life Sciences Opportunities IV LP Olema Pharmaceuticals Inc [2024-12-11] 8194.0
Point72 Asset Management LP Olema Pharmaceuticals Inc [2024-06-14] 5.7
Deep Track Capital LP Olema Pharmaceuticals Inc [2024-03-22] 5.44
BlackRock Inc Olema Pharmaceuticals Inc [2024-01-29] 6.0
Paradigm Biocapital Advisors LP Olema Pharmaceuticals Inc [2023-04-10] 6.2
Kynam Capital Management LP Olema Pharmaceuticals Inc [2023-02-10] 5.0
BlackRock Inc Olema Pharmaceuticals Inc [2022-07-08] 3.2
Fairmount Funds Management LLC Olema Pharmaceuticals Inc [2022-02-11] 5.2
Vanguard Group Inc Olema Pharmaceuticals Inc [2022-02-10] 5.33
BlackRock Inc Olema Pharmaceuticals Inc [2022-02-04] 5.7
RA Capital Management LP Olema Pharmaceuticals Inc [2021-02-16] 5.4
Janus Henderson Group PLC Olema Pharmaceuticals Inc [2021-02-12] 0.1
Wellington Management Group LLP Olema Pharmaceuticals Inc [2021-02-04] 5.15
Logos Global Management LP Olema Pharmaceuticals Inc [2020-12-03] 0.3
Cormorant Asset Management LP Olema Pharmaceuticals Inc [2020-11-23] 2.35
Biotechnology Value Fund L P Olema Pharmaceuticals Inc [2020-11-20] 8.5
Form 3/4/5 Filer 2011 - 2026
BVF Inc/IL
Biotechnology Value Trading Fund OS LP
Olema Pharmaceuticals Inc
BVF Partners L P/IL
Lampert Mark N
BVF GP Holdings LLC
BVF II GP LLC
BVF Partners OS Ltd
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
BVF I GP LLC
Harmon Cyrus
Larson Yi
Graham G Walmsley
Raman Prakash
Butitta Cynthia M
Rappaport Andrew
Clark Ian T
Garland J Scott
Hrustanovic Gorjan
Horning Sandra
Mitchell Shawnte
Austin Sasha Lu
Bohen Sean
Zojwalla Naseem
Myles David C
Kovacs Shane William Charles
Bain Capital Life Sciences IV General Partner LLC
Bain Capital Life Sciences Fund IV LP
Bain Capital Life Sciences Opportunities IV GP LLC
Bain Capital Life Sciences Opportunities IV LP
Bain Capital Life Sciences Investors LLC
Asefaw Senai
Paradigm BioCapital Advisors GP LLC
Paradigm BioCapital International Fund Ltd
Paradigm Biocapital Advisors LP
Moriarty John B
Horn Kinney
Kushner Peter J
Wellington Biomedical Innovation Master Investors Cayman I
McCormick Frank
Cormorant Private Healthcare Fund II LP
Cormorant Global Healthcare Master Fund LP
Chen Bihua
Cormorant Private Healthcare Fund III LP
Cormorant Asset Management LP
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Mitchell Shawnte
Stock Option (Right to Buy) · derivative
2026-03-04 Option exercise 25,000 $0.00
Mitchell Shawnte
Comon Stock
2026-03-04 Sell 233 $24.69 5,753
Mitchell Shawnte
Common Stock
2026-03-04 Sell 24,767 $24.25 600,600
Mitchell Shawnte
Common Stock
2026-03-04 Option exercise 25,000 $4.37 109,250
Mitchell Shawnte
Common Stock
2026-03-03 Option exercise 15,000 $4.37 65,550
Mitchell Shawnte
Stock Option (Right to Buy) · derivative
2026-03-03 Option exercise 15,000 $0.00
Mitchell Shawnte
Common Stock
2026-03-03 Sell 15,000 $23.01 345,150
Myles David C
Performance Stock Options (Right to Buy) · derivative
2026-02-02 Grant 106,250 $0.00
Austin Sasha Lu
Common Stock
2026-02-02 Grant 11,700 $0.00
Bohen Sean
Performance Stock Options (Right to Buy) · derivative
2026-02-02 Grant 275,000 $0.00
Bohen Sean
Stock Option (Right to Buy) · derivative
2026-02-02 Grant 850,000 $0.00
Mitchell Shawnte
Performance Stock Options (Right to Buy) · derivative
2026-02-02 Grant 56,250 $0.00
Zojwalla Naseem
Stock Option (Right to Buy) · derivative
2026-02-02 Grant 250,000 $0.00
Zojwalla Naseem
Performance Stock Options (Right to Buy) · derivative
2026-02-02 Grant 106,250 $0.00
Austin Sasha Lu
Stock Option (Right to Buy) · derivative
2026-02-02 Grant 29,250 $0.00
Mitchell Shawnte
Stock Option (Right to Buy) · derivative
2026-02-02 Grant 220,000 $0.00
Myles David C
Stock Option (Right to Buy) · derivative
2026-02-02 Grant 250,000 $0.00
Harmon Cyrus
Common Stock
2026-01-20 Sell 10,000 $26.88 268,800
Kovacs Shane William Charles
Common Stock
2026-01-15 Sell 100,000 $28.73 2,873,000
Myles David C
Common Stock
2026-01-14 Option exercise 50,000 $4.87 243,500
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 202 103,728,868
2025-12-31 204 91,256,578
2025-09-30 130 68,667,434
2025-06-30 123 70,581,268
2025-03-31 136 65,926,615
2024-12-31 160 71,474,057
2024-09-30 132 58,894,129
2024-06-30 129 61,219,535
2024-03-31 128 57,226,137
2023-12-31 114 52,858,821
2023-09-30 97 46,997,193
2023-06-30 88 35,900,723
Form 13F Holdings
Firm Period DFND Voting Shares
Hennion & Walsh Asset Management Inc [2026-06-30] SOLE 420,211 420,211
TEMA ETFS LLC [2026-06-30] SOLE 79,759 79,759
Swedbank AB [2026-06-30] DFND 55,100 55,100
PSP Research LLC [2026-06-30] SOLE 0 10,000
Versant Capital Management Inc [2026-06-30] SOLE 1,198 1,198
Wolff Wiese Magana LLC [2026-06-30] SOLE 600 600
Gamma Investing LLC [2026-06-30] DFND 596 596
Physician Wealth Advisors Inc [2026-06-30] SOLE 0 391
Farther Finance Advisors LLC [2026-06-30] SOLE 0 180
True Wealth Design LLC [2026-06-30] SOLE 0 61
Ares Financial Consulting LLC [2026-06-30] SOLE 24 24
IFP Advisors LLC [2026-06-30] SOLE 6 6
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com